Announced Wed, 26 Aug · 16:55 IST

Board Approves IP Portfolio Buy from Related Party for Up to 10 Crore

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹116.65
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+3.7+3.7+3.7+8.0+4.7-0.9
Up moveDown movePending
AI summary

Arvaya Healthcare's board approved acquiring the Copyright and IP portfolio of DEFIB Institute of Health Solutions LLP, a related party, for up to 10 Crore rupees. The deal will be funded from the Rights Issue proceeds and is structured as an IP assignment, not a slump sale. Originally the agenda was to acquire Navahmedi Solution's business undertaking, but scope was revised at the meeting. Being a material related party transaction, it requires shareholder approval under SEBI LODR Regulation 23. The Audit Committee reviewed and recommended the draft agreement and valuation report.

Likely market impact

Uses Rights Issue money for a related-party IP purchase. Shareholder approval is required. Investors should check valuation fairness and conflict-of-interest terms.